GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. Estimate-0.13-0.13-0.49-0.34
Low Estimate-0.13-0.13-0.49-0.34
High Estimate-0.13-0.13-0.49-0.34
Year Ago EPS-0.19-0.12-0.76-0.49
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. EstimateN/AN/AN/A20M
Low EstimateN/AN/AN/A20M
High EstimateN/AN/AN/A20M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.-0.22-0.17-0.16-0.15
EPS Actual-0.19-0.12-0.15-0.14
Difference0.030.050.010.01
Surprise %13.60%29.40%6.30%6.70%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate-0.13-0.13-0.49-0.34
7 Days Ago-0.14-0.13-0.53-0.57
30 Days Ago-0.15-0.12-0.56-0.79
60 Days Ago-0.15-0.12-0.56-0.79
90 Days Ago-0.15-0.12-0.56-0.79
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesGALTIndustrySectorS&P 500
Current Qtr.31.60%N/AN/A0.15
Next Qtr.-8.30%N/AN/A0.27
Current Year35.50%N/AN/A0.07
Next Year30.60%N/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A